Invesco Nasdaq Biotechnology ETF (IBBQ) Short Interest Ratio & Short Volume → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free IBBQ Stock Alerts $20.70 +0.18 (+0.88%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Invesco Nasdaq Biotechnology ETF Short Interest DataCurrent Short Volume25,700 sharesPrevious Short Volume8,200 sharesChange Vs. Previous Month+213.41%Dollar Volume Sold Short$533,018.00Short Interest Ratio / Days to Cover1.4Last Record DateApril 15, 2024Outstanding Shares1,470,000 sharesPercentage of Shares Shorted1.75%Today's Trading Volume10,554 sharesAverage Trading Volume20,123 sharesToday's Volume Vs. Average52% Short Selling Invesco Nasdaq Biotechnology ETF ? Sign up to receive the latest short interest report for Invesco Nasdaq Biotechnology ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIBBQ Short Interest Over TimeIBBQ Days to Cover Over TimeIBBQ Percentage of Float Shorted Over Time Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. Invesco Nasdaq Biotechnology ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202425,700 shares $533,018.00 +213.4%N/A1.4 $20.74 3/31/20248,200 shares $181,876.00 +4,000.0%N/A0.4 $22.18 3/15/2024200 shares $4,382.00 -90.0%N/A0 $21.91 2/29/20242,000 shares $44,380.00 -83.3%N/A0.1 $22.19 2/15/202412,000 shares $266,400.00 -37.8%N/A0.6 $22.20 1/31/202419,300 shares $423,056.00 -9.0%N/A1 $21.92 Get the Latest News and Ratings for IBBQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 1/15/202421,200 shares $474,244.00 -70.1%N/A1.2 $22.37 12/31/202371,000 shares $1.55 million +822.1%N/A4.7 $21.89 12/15/20237,700 shares $163,009.00 +120.0%N/A0.8 $21.17 11/30/20233,500 shares $67,900.00 -2.8%N/A0.5 $19.40 11/15/20233,600 shares $68,148.00 +227.3%N/A0.6 $18.93 10/31/20231,100 shares $20,372.00 -31.3%N/A0.2 $18.52 10/15/20231,600 shares $31,536.00 +433.3%N/A0.3 $19.71 9/30/2023300 shares $5,946.00 +50.0%N/A0 $19.82 9/15/2023200 shares $4,066.00 -97.4%N/A0 $20.33 8/31/20237,700 shares $159,005.00 +120.0%N/A1.2 $20.65 8/15/20233,500 shares $71,855.00 +59.1%N/A0.5 $20.53 7/31/20232,200 shares $45,496.00 +340.0%N/A0.3 $20.68 7/15/2023500 shares $10,280.00 -16.7%N/A0.1 $20.56 6/30/2023600 shares $12,258.00 +20.0%N/A0.1 $20.43 6/15/2023500 shares $10,645.00 +66.7%N/A0.1 $21.29 5/31/2023300 shares $6,123.00 -50.0%N/A0 $20.41 5/15/2023600 shares $12,822.00 -33.3%N/A0.1 $21.37 IBBQ Short Interest - Frequently Asked Questions What is Invesco Nasdaq Biotechnology ETF's current short interest? Short interest is the volume of Invesco Nasdaq Biotechnology ETF shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 25,700 shares of IBBQ short. Learn More on Invesco Nasdaq Biotechnology ETF's current short interest. What is a good short interest ratio for Invesco Nasdaq Biotechnology ETF? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IBBQ shares currently have a short interest ratio of 1.0. Learn More on Invesco Nasdaq Biotechnology ETF's short interest ratio. Is Invesco Nasdaq Biotechnology ETF's short interest increasing or decreasing? Invesco Nasdaq Biotechnology ETF saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 25,700 shares, an increase of 213.4% from the previous total of 8,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Invesco Nasdaq Biotechnology ETF's short interest compare to its competitors? Here is how the short interest of companies compare to Invesco Nasdaq Biotechnology ETF: Principal Healthcare Innovators ETF (0.29%), First Trust Nasdaq Pharmaceuticals ETF (0.13%), JPMorgan Healthcare Leaders ETF (0.08%), ProShares UltraShort Nasdaq Biotechnology (7.88%), ProShares Ultra Nasdaq Biotechnology (2.28%), Invesco S&P SmallCap Health Care ETF (0.03%), VanEck Biotech ETF (0.09%), VanEck Pharmaceutical ETF (24.39%), and iShares Biotechnology ETF (15.72%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Invesco Nasdaq Biotechnology ETF stock? Short selling IBBQ is an investing strategy that aims to generate trading profit from Invesco Nasdaq Biotechnology ETF as its price is falling. IBBQ shares are trading up $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Invesco Nasdaq Biotechnology ETF? A short squeeze for Invesco Nasdaq Biotechnology ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IBBQ, which in turn drives the price of the stock up even further. How often is Invesco Nasdaq Biotechnology ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IBBQ, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: BTEC Short Interest Data FTXH Short Interest Data JDOC Short Interest Data BIS Short Interest Data BIB Short Interest Data PSCH Short Interest Data BBH Short Interest Data PPH Short Interest Data IBB Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IBBQ) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlaceMan Who Predicted 2008: “This Will be Worse.”Altimetry